{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:23:51Z","timestamp":1793197431570,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10096-015-2406-x","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T06:36:16Z","timestamp":1431930976000},"page":"1693-1699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit"],"prefix":"10.1007","volume":"34","author":[{"given":"H.","family":"Habayeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sajin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Al-Dujaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"2406_CR1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/jac\/dkr103","volume":"66","author":"CC Lai","year":"2011","unstructured":"Lai CC, Wang CY, Chu CC, Tan CK, Lu CL, Lee YC, Huang YT, Lee PI, Hsueh PR (2011) Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. J Antimicrob Chemother 66:1374\u20131382","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1128\/AAC.46.3.854-858.2002","volume":"46","author":"AD Harris","year":"2002","unstructured":"Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA (2002) Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother 46:854\u2013858","journal-title":"Antimicrob Agents Chemother"},{"key":"2406_CR3","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1128\/AAC.00607-13","volume":"57","author":"M McLaughlin","year":"2013","unstructured":"McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH (2013) Correlations of antibiotic use and carbapenem resistance in Enterobacteriaceae. Antimicrob Agents Chemother 57:5131\u20135133","journal-title":"Antimicrob Agents Chemother"},{"key":"2406_CR4","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/jac\/dks213","volume":"67","author":"PC Appelbaum","year":"2012","unstructured":"Appelbaum PC (2012) 2012 and beyond: potential for the start of a second pre-antibiotic era? J Antimicrob Chemother 67:2062\u20132068","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR5","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/jac\/dkp255","volume":"64","author":"DM Livermore","year":"2009","unstructured":"Livermore DM (2009) Has the era of untreatable infections arrived? J Antimicrob Chemother 64:i29\u2013i36","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkn511","volume":"63","author":"DM Livermore","year":"2009","unstructured":"Livermore DM, Tulkens PM (2009) Temocillin revived. J Antimicrob Chemother 63:243\u2013245","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR7","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkr317","volume":"66","author":"I Balakrishnan","year":"2011","unstructured":"Balakrishnan I, Awad-El-Kariem FM, Aali A, Kumari P, Mulla R, Tan B, Brudney D, Ladenheim D, Ghazy A, Khan I, Virgincar N, Iyer S, Carryn S, Van de Velde S (2011) Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and\/or derepressed AmpC {beta}-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 66:2628\u20132631","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/dkq388","volume":"66","author":"H Rodriguez-Villalobos","year":"2011","unstructured":"Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, Montesinos I, de Mendonca R, Jans B, Glupczynski Y (2011) Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother 66:37\u201347","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR9","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/jac\/dkl043","volume":"57","author":"DM Livermore","year":"2006","unstructured":"Livermore DM, Hope R, Fagan EJ, Warner M, Woodford N, Potz N (2006) Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England. J Antimicrob Chemother 57:1012\u20131014","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jac\/dkt383","volume":"69","author":"N Woodford","year":"2014","unstructured":"Woodford N, Pike R, Meunier D, Loy R, Hill R, Hopkins KL (2014) In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase. J Antimicrob Chemother 69:564\u2013567","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377\u2013382","journal-title":"Thorax"},{"key":"2406_CR12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/09674845.2009.11730269","volume":"66","author":"MWD Wren","year":"2009","unstructured":"Wren MWD, Kinson R, Sivapalan M, Shemko M, Shetty NR (2009) Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm. Br J Biomed Sci 66:175\u2013179","journal-title":"Br J Biomed Sci"},{"key":"2406_CR13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.diagmicrobio.2014.07.007","volume":"80","author":"C Rahme","year":"2014","unstructured":"Rahme C, Butterfield JM, Nicasio AM, Lodise TP (2014) Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit? Diagn Microbiol Infect Dis 80:239\u2013259","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2406_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/AAC.25.1.142","volume":"25","author":"L Verbist","year":"1984","unstructured":"Verbist L, Verhaegen J (1984) Effect of temocillin in combination with other beta-lactam antibiotics. Antimicrob Agents Chemother 25:142\u2013144","journal-title":"Antimicrob Agents Chemother"},{"key":"2406_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/505393","volume":"43","author":"EJ Bow","year":"2006","unstructured":"Bow EJ, Rotstein C, Noskin GA, Laverdiere M, Schwarer AP, Segal BH, Seymour JF, Szer J, Sanche S (2006) A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. Clin Infect Dis 43:447\u2013459","journal-title":"Clin Infect Dis"},{"key":"2406_CR16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10156-013-0605-x","volume":"19","author":"F Karino","year":"2013","unstructured":"Karino F, Miura K, Fuchita H, Koba N, Nishikawa E, Hotta T, Okimoto T, Iwamoto S, Tsubata Y, Tada M, Hamaguchi S, Honda T, Ohe M, Sutani A, Kuraki T, Takeyama H, Isobe T (2013) Efficacy and safety of piperacillin\/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia. J Infect Chemother 19:909\u2013915","journal-title":"J Infect Chemother"},{"key":"2406_CR17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jac\/dki120","volume":"55","author":"SD Baines","year":"2005","unstructured":"Baines SD, Freeman J, Wilcox MH (2005) Effects of piperacillin\/tazobactam on Clostridium difficile growth and toxin production in a human gut model. J Antimicrob Chemother 55:974\u2013982","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkh285","volume":"54","author":"MH Wilcox","year":"2004","unstructured":"Wilcox MH, Freeman J, Fawley W, MacKinlay S, Brown A, Donaldson K, Corrado O (2004) Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. J Antimicrob Chemother 54:168\u2013172","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR19","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jac\/dkh127","volume":"53","author":"WK Alston","year":"2004","unstructured":"Alston WK, Ahern JW (2004) Increase in the rate of nosocomial Clostridium difficile-associated diarrhoea during shortages of piperacillin-tazobactam and piperacillin. J Antimicrob Chemother 53:549\u2013550","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1592\/phco.2006.26.1.61","volume":"26","author":"MN Mendez","year":"2006","unstructured":"Mendez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo BJ (2006) Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections. Pharmacotherapy 26:61\u201367","journal-title":"Pharmacotherapy"},{"key":"2406_CR21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/TA.0b013e31823c5637","volume":"72","author":"K Shah","year":"2012","unstructured":"Shah K, Pass LA, Cox M, Lanham M, Arnold FW (2012) Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients. J Trauma Acute Care Surg 72:691\u2013695","journal-title":"J Trauma Acute Care Surg"},{"key":"2406_CR22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.diagmicrobio.2010.07.017","volume":"68","author":"IT Balassiano","year":"2010","unstructured":"Balassiano IT, Dos Santos-Filho J, de Oliveira MP, Ramos MC, Japiassu AM, Dos Reis AM, Brazier JS, de Oliveira FE, Domingues RM (2010) An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil. Diagn Microbiol Infect Dis 68:449\u2013455","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2406_CR23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/jac\/dkp128","volume":"63","author":"N Vernaz","year":"2009","unstructured":"Vernaz N, Hill K, Leggeat S, Nathwani D, Philips G, Bonnabry P, Davey P (2009) Temporal effects of antibiotic use and Clostridium difficile infections. J Antimicrob Chemother 63:1272\u20131275","journal-title":"J Antimicrob Chemother"},{"key":"2406_CR24","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1046\/j.1365-2036.1998.00428.x","volume":"12","author":"CD Settle","year":"1998","unstructured":"Settle CD, Wilcox MH, Fawley WN, Corrado OJ, Hawkey PM (1998) Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam. Aliment Pharmacol Ther 12:1217\u20131223","journal-title":"Aliment Pharmacol Ther"},{"key":"2406_CR25","first-page":"1567","volume":"4","author":"E Yeung","year":"2012","unstructured":"Yeung E, Gore JG, Auersperg EV (2012) A retrospective analysis of the incidence of clostridium difficile associated diarrhea with meropenem and piperacillin-tazobactam. Int J Collab Res Intern Med Public Health 4:1567\u20131576","journal-title":"Int J Collab Res Intern Med Public Health"},{"key":"2406_CR26","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/dkt477","volume":"69","author":"C Slimings","year":"2014","unstructured":"Slimings C, Riley TV (2014) Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 69:881\u2013891","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"2406_CR27","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.qco.0000393485.17894.4c","volume":"24","author":"EJC Goldstein","year":"2011","unstructured":"Goldstein EJC (2011) Beyond the target pathogen: ecological effects of the hospital formulary. Curr Opin Infect Dis 24(Suppl 1):S21\u2013S31","journal-title":"Curr Opin Infect Dis"},{"key":"2406_CR28","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/AAC.27.6.980","volume":"27","author":"RJ Boon","year":"1985","unstructured":"Boon RJ, Beale AS (1985) Studies with temocillin in a hamster model of antibiotic-associated colitis. Antimicrob Agents Chemother 27:980\u2013981","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 5","key":"2406_CR29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00003495-198500295-00010","volume":"29","author":"HW Mittermayer","year":"1985","unstructured":"Mittermayer HW (1985) Influence of temocillin on human bowel flora. Drugs 29(Suppl 5):43\u201348","journal-title":"Drugs"},{"key":"2406_CR30","volume":"4","author":"P Davey","year":"2013","unstructured":"Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, Ramsay CR, Wiffen PJ, Wilcox M (2013) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 4:CD003543","journal-title":"Cochrane Database Syst Rev"},{"key":"2406_CR31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3947\/ic.2013.45.4.351","volume":"45","author":"JY Song","year":"2013","unstructured":"Song JY, Eun BW, Nahm MH (2013) Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward. Infect Chemother 45:351\u2013366","journal-title":"Infect Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2406-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-015-2406-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2406-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T18:52:20Z","timestamp":1553626340000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-015-2406-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2406"],"URL":"https:\/\/doi.org\/10.1007\/s10096-015-2406-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}